Ball Jack 4
4 · Cytek Biosciences, Inc. · Filed Nov 16, 2022
Insider Transaction Report
Form 4
Ball Jack
Director
Transactions
- Exercise/Conversion
Common Stock
2022-11-14$0.40/sh+16,000$6,400→ 19,000 total - Sale
Common Stock
2022-11-14$14.69/sh−16,000$235,040→ 3,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-11-14−16,000→ 10,666 totalExercise: $0.40From: 2020-10-12Exp: 2028-10-12→ Common Stock (16,000 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 12, 2022.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.53 to $14.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.